With the announcement last week of its plans to acquire Shanghai-based Bio Asia, a 5-year-old reagent manufacturer and R&D services provider, Invitrogen took another step in ramping up its presence in the Asia-Pacific market, which CEO Greg Lucier described as the “real gem of our business.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.